DE2062558A1 - Mittel zur Diagnose von primärem Leberkrebs und Verfahren zur Her stellung desselben - Google Patents

Mittel zur Diagnose von primärem Leberkrebs und Verfahren zur Her stellung desselben

Info

Publication number
DE2062558A1
DE2062558A1 DE19702062558 DE2062558A DE2062558A1 DE 2062558 A1 DE2062558 A1 DE 2062558A1 DE 19702062558 DE19702062558 DE 19702062558 DE 2062558 A DE2062558 A DE 2062558A DE 2062558 A1 DE2062558 A1 DE 2062558A1
Authority
DE
Germany
Prior art keywords
serum
fetoglobulin
carrier material
buffer
dye
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19702062558
Other languages
German (de)
English (en)
Inventor
Hidetaka Hachioji Tokio Sato Eiichi Funabashi Chiba Kobayashi Fujio Higashimurayama Maeda Kunihiro Musashmo Tokio Nagai, (Japan)
Original Assignee
Kowa Co , Ltd , Nagoya (Japan)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP44101870A external-priority patent/JPS49485B1/ja
Priority claimed from JP45066238A external-priority patent/JPS4948729B1/ja
Priority claimed from JP45075452A external-priority patent/JPS4843855B1/ja
Application filed by Kowa Co , Ltd , Nagoya (Japan) filed Critical Kowa Co , Ltd , Nagoya (Japan)
Publication of DE2062558A1 publication Critical patent/DE2062558A1/de
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/303—Liver or Pancreas
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/549—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic with antigen or antibody entrapped within the carrier

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE19702062558 1969-12-18 1970-12-18 Mittel zur Diagnose von primärem Leberkrebs und Verfahren zur Her stellung desselben Pending DE2062558A1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP44101870A JPS49485B1 (https=) 1969-12-18 1969-12-18
JP1433570 1970-02-19
JP45066238A JPS4948729B1 (https=) 1970-07-29 1970-07-29
JP45075452A JPS4843855B1 (https=) 1970-08-28 1970-08-28

Publications (1)

Publication Number Publication Date
DE2062558A1 true DE2062558A1 (de) 1971-06-24

Family

ID=27456179

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19702062558 Pending DE2062558A1 (de) 1969-12-18 1970-12-18 Mittel zur Diagnose von primärem Leberkrebs und Verfahren zur Her stellung desselben

Country Status (8)

Country Link
BE (1) BE760366A (https=)
CA (1) CA956554A (https=)
CH (1) CH537190A (https=)
DE (1) DE2062558A1 (https=)
DK (1) DK131129B (https=)
FR (1) FR2077560A1 (https=)
GB (1) GB1339737A (https=)
SE (1) SE388284B (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0021236A1 (en) * 1979-06-13 1981-01-07 Mitsubishi Kasei Corporation Method for optically assaying liquid samples
EP0215457A3 (en) * 1985-09-12 1987-09-09 Boehringer Mannheim Gmbh Method for the determination of a partner of an immuno-reaction
CN115308010A (zh) * 2021-05-06 2022-11-08 威高集团有限公司 一种抗体保护剂和采血管

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3129049A (en) * 1960-12-05 1964-04-14 Westinghouse Electric Corp Terminal assembly shield
JPS548714A (en) * 1977-06-16 1979-01-23 Saikin Kagaku Kenkiyuushiyo Kk Production of specific antiserum

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0021236A1 (en) * 1979-06-13 1981-01-07 Mitsubishi Kasei Corporation Method for optically assaying liquid samples
EP0215457A3 (en) * 1985-09-12 1987-09-09 Boehringer Mannheim Gmbh Method for the determination of a partner of an immuno-reaction
CN115308010A (zh) * 2021-05-06 2022-11-08 威高集团有限公司 一种抗体保护剂和采血管

Also Published As

Publication number Publication date
DK131129C (https=) 1975-12-22
BE760366A (fr) 1971-06-15
GB1339737A (en) 1973-12-05
DK131129B (da) 1975-06-02
FR2077560A1 (https=) 1971-10-29
CH537190A (fr) 1973-05-31
SE388284B (sv) 1976-09-27
CA956554A (en) 1974-10-22

Similar Documents

Publication Publication Date Title
DE2029499C3 (de) Verfahren zum Nachweis der Anwesenheit von carcinoembryonalen Antigenen im Blut
EP0021152B1 (de) Verfahren zur immunologischen Bestimmung von Basalmembranmaterial, hierfür geeignete Basalmembranfragmente und Verfahren zu deren Herstellung, bzw. Gewinnung
CH658317A5 (de) Verfahren zur feststellung von krebs beim menschen.
CH627187A5 (https=)
EP0060491B1 (de) Protein (PP16), Verfahren zu seiner Anreicherung und Gewinnung sowie seine Verwendung
DE2640387C3 (de) Gewebespezifisches Protein und Verfahren zu dessen Herstellung
EP0101603B1 (de) Neues Protein (PP13), Verfahren zu seiner Anreicherung und Gewinnung sowie seine Verwendung
EP0037963B1 (de) Neues Protein PP9, Verfahren zu seiner Gewinnung sowie seine Verwendung
DE2616984C3 (de) Verfahren zur Isolierung und Reinigung eines plazentenspezifischen Glycoproteins
EP0141326B1 (de) Neues Protein PP20, Verfahren zu seiner Gewinnung sowie seine Verwendung
EP0165476A2 (de) Gewebeprotein PP18, Verfahren zu seiner Gewinnung sowie seine Verwendung
DE1767899A1 (de) Verfahren zur Isolierung von Antigenen und Antikoerpern
DE2062558A1 (de) Mittel zur Diagnose von primärem Leberkrebs und Verfahren zur Her stellung desselben
EP0029191B1 (de) Neues Protein PP11, ein Verfahren zu seiner Gewinnung und seine Verwendung
CH636449A5 (de) Verfahren zur gewinnung eines neuen, spezifischen alpha-l-antikoerpers.
DE2742835A1 (de) Antigenfraktionen von schistosoma mansoni-eiern, geeignet fuer die untersuchung von schistosomiasis
EP0156266A2 (de) Gewebeprotein PP21, Verfahren zu seiner Gewinnung sowie seine Verwendung
DE2126128A1 (de) Medizinisches Testverfahren, Reagens und Additiv zur Durchführung des Verfahrens
DE2333740C2 (de) Verwendung eines Hämagglutinations-Hemmverfahrens zur Ermittlung von Krebs
DE2157610C3 (de) Schwangerschaftsspezifisches ß , -Glykoprotein, Verfahren zu seiner Isolierung und seine Verwendung für die Herstellung von Antiseren
EP0013306B1 (de) Verfahren zur Bestimmung eines opsonierenden oberflächenbindenden alpha-2-Glykoproteins
DE3511199A1 (de) Verfahren zur immunologischen bestimmung von heparansulfat-proteoglykan, verfahren zur herstellung bzw. reinigung von dafuer geeignetem heparansulfat-proteoglykan aus basalmembran-haltigen geweben
DE1798170C2 (de) Verfahren zur Bestimmung der Anwesenheit von gegen bestimmte Allergene gerichteten Reagin-Immunoglobulinen (Reagin-Ig) in wäßrigen Proben
DE2933015A1 (de) Verfahren zur herstellung der dritten komponente des komplements aus menschlichem blutplasma
DE1959608C (de) Verfahren zur Gewinnung von AntiSerum für die Hepatomdiagnose

Legal Events

Date Code Title Description
OHB Non-payment of the publication fee (examined application)